| Product Type | Impurity Standards |
| CAT. No. | MRL-V07009 |
| CAS. No. | NA |
| Mol. Formula | C12H16N4O6S |
| Mol. Weight | 344.34 |
| Synonyms | NA |
| Chemical Name | 3-Nitro-4-(nitroso((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Venetoclax. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Venetoclax is a BCL-2 inhibitor prescribed for the treatment of certain blood cancers, notably chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Operating by inhibiting the B-cell lymphoma-2 (BCL-2) protein, Venetoclax disrupts the survival mechanisms of cancer cells, triggering programmed cell death. It is often utilized in combination with other anti-cancer drugs, particularly in cases where the cancer cells exhibit the 17p deletion genetic abnormality, making them less responsive to standard treatments. Buy high quality N-Nitroso Venetoclax Impurity 5 from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Venetoclax Impurity 5